Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2012 | 1 |
2016 | 1 |
2019 | 1 |
2024 | 0 |
Search Results
3 results
Results by year
Filters applied: . Clear all
Page 1
An up-to-date evaluation of alogliptin benzoate for the treatment of type 2 diabetes.
Expert Opin Pharmacother. 2019 Oct;20(14):1679-1687. doi: 10.1080/14656566.2019.1645124. Epub 2019 Jul 23.
Expert Opin Pharmacother. 2019.
PMID: 31335214
Review.
Areas covered: This article provides a comprehensive review of the latest data on alogliptin benzoate, including hypoglycemic activity and safety. Expert opinion: The cumulative evidence for alogliptin benzoate is robust with regards to glycemic effica …
Areas covered: This article provides a comprehensive review of the latest data on alogliptin benzoate, including hypoglycemic …
Alogliptin benzoate for the treatment of type 2 diabetes.
Rendell M, Drincic A, Andukuri R.
Rendell M, et al.
Expert Opin Pharmacother. 2012 Mar;13(4):553-63. doi: 10.1517/14656566.2012.656088. Epub 2012 Feb 1.
Expert Opin Pharmacother. 2012.
PMID: 22296609
Review.
The glucose-lowering effect of this agent is discussed as monotherapy and in combination with metformin, sulfonylurea, piogilitazone and insulin. The potential adverse effects of alogliptin are summarized. Alogliptin is compared with the other availabl …
The glucose-lowering effect of this agent is discussed as monotherapy and in combination with metformin, sulfonylurea, piogili …
Item in Clipboard
A guide for using experimental design in chromatographic method development: applied to the analysis of selected anti-diabetic pharmaceutical combinations.
Ayoub BM, Abdel-Aziz O.
Ayoub BM, et al.
Pharmazie. 2016 Dec 1;71(12):683-690. doi: 10.1691/ph.2016.6095.
Pharmazie. 2016.
PMID: 29441996
A guide experimental design in chromatographic method development was described and applied successfully to the analysis of different recently approved anti-diabetic pharmaceutical combinations. Enhancement of UHPLC analysis of alogliptin benzoate either with …
A guide experimental design in chromatographic method development was described and applied successfully to the analysis of different recent …
Item in Clipboard
Cite
Cite